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Summary 
Several authors have suggested that Dexamethasone Suppression Test (DST) non-suppression is related 
to circadian alternations of hypothalamic-pituitary-adrenal function. Two clinical manifestations of 
altered circadian rhythms in depressed patients are early morning awakening and diurnal variation in 
mood. To observe whether these clinical symptom patterns were associated with an increased frequency of 
abnormal DSTs, we examined post-DST plasma cortisol concentrations and matched clinical ratings of 
early morning awakening and diurnal variation in mood in 49 patients with major depressive disorder, 
endogenous subtype. We found no significant association between these clinical and laboratory variables. 
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Introduction 
Early morning awakening and diurnal variation 
of mood are distinctive features of affective dis- 
orders (Haider 1968; Mellerup and Rafaelsen 1979; 
Hamilton 1982; Wehr and Wirz-Justice 1982). Each 
symptom is currently incorporated into the Re- 
search Diagnostic Criteria (Spitzer et al. 1977) and 
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the DSM-III (American Psychiatric Association 
1978) as diagnostic parameters for Major Depres- 
sive Disorder, endogenous or melancholic subtype. 
Each symptom has been linked with the circadian 
rhythm alterations noted in endogenous depres- 
sion (Rafaelsen and Mellerup 1977; Stroebell981; 
Wehr and Wirz-Justice 1982). Neuroendocrine 
abnormalities in circadian patterns in patients with 
Major Depressive Disorder have been reported for 
prolactin (Halbreich et al. 1979; Mendelewicz et 
al. 1980), and ACTH and cortisol (Sachar 1976; 
Reus et al. 1982), suggesting that the basic limbic 
physiopathology in affective disorders is related to 
a desynchronization and phase shifting of ‘ biologi- 
cal clocks’ controlling the circadian rhythms (Mel- 
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lerup and Rafaelsen 1979; Wehr et al. 1979; Pepper 
et al. 1983). 
The dexamethasone suppression test (DST) has 
been proposed as a biological correlate for major 
depressive disorder endogenous subtype (Carroll 
et al. 1981). Folllowing the 1 mg overnight stan- 
dardized DST, 30-60s of patients show non-sup- 
pression at one or more of three time points, 8:00 
am, 4:00 pm, or 11:OO pm (Carroll 1982) de- 
pending upon dose of dexamethasone, number of 
plasma samples, type of cortisol assay and other 
sources of variance. DST non-suppression is hy- 
pothesized to be an expression of limbicchypo- 
thalamiccpituitary-adrenal (LHPA) axis disin- 
hibition. This disinhibition, in turn, has been at- 
tributed to altered circadian rhythmicity (Wehr 
and Wirz-Justice 1982) overriding the inhibitory 
effects on the dexamethasone. 
Most studies dealing with circadian clinical pat- 
terns in affective disorders have not assessed 
simultaneously biological markers. To evaluate 
possible associations between self-reported diurnal 
variation of mood, early morning awakening, and 
DST results in hospitalized patients with endoge- 
nous depression, we tested the hypothesis that 
patients with these two clinical features would 
show increased DST non-suppression. Our find- 
ings failed to support this hypothesis. 
Patients and Methods 
We studied 49 patients hospitalized in the Clini- 
cal Studies Unit of the University of Michigan 
Psychiatric Hospitals. We evaluated each patient 
with our standard diagnostic procedure, which in- 
cludes a clinical interview by one or two faculty 
psychiatrists, a structured interview using the 
Schedule for Affective Disorders and Schizoph- 
renia (SADS) (Spitzer and Endicott 1975) a di- 
agnostic family interview, a review of past medical 
records whenever available, and a comprehensive 
physical examination and laboratory screening to 
rule out significant medical illness. In order to 
participate in the study, patients needed: (1) in- 
formed consent for participation; (2) a diagnosis 
of major depressive disorder endogenous subtype 
by Research Diagnostic Criteria (Spitzer et al. 
1977); (3) a DST performed in conjunction with 
clinical ratings of diurnal variation of mood and 
early morning awakening; (4) the absence of ex- 
elusion criteria for the DST (Carroll et al. 1981); 
(5) a score of 12 or more in the 17-item Hamilton 
Rating Scale for Depression (HRSD) (Hamilton 
1960). only three subjects had HRSDs of less than 
16; (6) self-reported diurnal variation of mood and 
early morning awakening. Ratings were performed 
during the first week of hospitalization by clini- 
cians blind to DST results. We used the standar- 
dized 1 mg overnight DST. accepting 5 pg/dl as a 
cutting value for non-suppression using the com- 
petitive protein-binding method of Murphy for 
cortisol assays (Carroll et al. 1981). Patients with 
any post-dexamethasone cortisol level (from either 
8:00 am, 4:00 pm, or 11:OO pm) which exceeded 5 
pg/dl were considered non-suppressors. 
We rated early morning awakening as present if 
the patient awakened l-3 h earlier than usual and 
was unable to fall asleep again as documented by 
nurses’ observations. We chose this operational 
definition of early morning awakening to differen- 
tiate with middle insomnia. We considered diurnal 
variation of mood to be present only if the patient 
reported that mornings were distinctively worse 
than evenings and ward observations by staff con- 
firmed this complaint. To enhance homogeneity, 
only patients who definitely had or did not have 
each of the symptoms were included in the study. 
Because weight loss has been suggested to invali- 
date DSTs (Berger et al. 1983; Edelstein et al. 
1983). we recorded patients’ reports on weight 
changes throughout the current episode, grouping 
together those patients with reported losses of 1 kg 
or more. Most patients were being tapered off 
their psychotropic medication(s) in preparation for 
the drug-free period usually in effect in our unit; 
15 patients were already drug-free at the moment 
of testing, 28 patients were receiving antide- 
pressants or antianxiety medications and 6 were 
on antipsychotics. No medication received is 
known to affect DST results (Carroll et al. 1981). 
Prior to conducting statistical analysis we log 
transformed plasma cortisol concentrations in 
order to improve normality of distribution and 
equality of variance. HRSD scores, age and post- 
DST cortisol values were analyzed using 2-tailed 
Student’s t-tests. Sex, weight loss, endogenous fea- 
tures and categorical suppressive and non-suppres- 
sive status were analyzed using chi-squares with 


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Demographic features are listed in Table 1. 
Forty-nine patients, 15 males (age range 21-68, 
mean 48.26) and 34 females (age range 26-78, 
mean 46.7) were included in the study. All 49 
patients had valid 8:00 am postdexamethasone 
cortisol samples; only 46 had complete (8:00 am, 
4:00 pm, 11:OO pm) post-dexamethasone sampling. 
Fifty-six percent of the total sample had a non- 
suppressive DST (31% at 8:00 am, 32% at 4:00 
pm, 35% at 11:OO pm). 
Nineteen of 49 patients (38%) reported having 
distinctive diurnal variation of depression. We 
identified no significant differences in sexual dis- 
tribution, age, HRSD ratings, or diagnosis of en- 
dogenous subtype (definite or probable) between 
patients with and without diurnal variation (Table 
1). Diurnal variation was not associated with higher 
cortisol values nor increased frequency of abnormal 
DSTs at any of the post-dexamethasone cortisol 
samplings (Table 2). 
Twenty-three of 49 patients (47%) reported early 
morning awakening. In this group, the severity of 
the depression was compared by subtracting the 
early morning awakening ratings in the HRSD 
from the total HRSD rating. Patients having dis- 
tinct early morning awakening were significantly 
more depressed (t = - 2.66, P -c 0.01) than those 
without it. Other parameters (sexual distribution, 
age, and definite or probable diagnosis of endoge- 
nous subtype) were similar in both groups (Table 
1). Even though patients with early morning 
awakening were significantly more depressed, they 
showed no differences in their cortisol values and 
categorical DST responses, neither for the 8:00 am 
nor for the overall sampling of post-dexametha- 
sone cortisols (Table 2). 
Fifteen of 49 patients (31%) reported having 
diurnal variation and early morning awakening 
simultaneously. As for the other groups (demo- 
graphical or cortisol related), no distinctive fea- 
tures were noted for these patients, HRSD ratings 
did not differentiate between the groups (Tables 1 
and 2). 
We compared patients reporting weight loss 
during the episode with those reporting no weight 
change or weight gain. No significant differences 
were found between the groups for any of the 
post-DST plasma cortisol samples (Table 2). 
We were unable to identify any significant as- 
sociation between abnormal diurnal circadian pat- 
terns-represented by diurnal variation of mood 
and early morning awakening-and DST results 
in this sample of 49 patients with endogenous 
depression. We had hypothesized that patients with 
symptoms suggestive of altered circadian regu- 
lation would show abnormal DST results more 
often, presumably due to a phase advancement in 
cortisol secretion patterns. We failed to find this, 
however. Brown and Shuey (1980) reached a simi- 
lar conclusion and reported that patients without 
diurnal variation of mood had a higher frequency 
of abnormal (2 mg) DST results. Pepper et al. 
(1983) used a different approach to study possible 
associations between circadian factors and DST 
results by alternatively administering 1 mg of de- 
xamethasone at 11:30 pm and 7:00 pm to 6 pa- 
tients with Major Depressive Disorder. They found 
similar post-dexamethasone responses in suppres- 
sors and non-suppressors at both times of admin- 
istration of the drug and concluded that DST 
results were unaffected by changing the hour of 
administration of the dexamethasone. They stated, 
as Carroll et al. (1968) had done previously, that 
phase advancement in cortisol secretion patterns 
does not seem to play a role in DST non-suppres- 
sion. Abnormal DSTs have been reported after 
anticholinergic withdrawal (Greden et al. 1983) 
particularly after abrupt withdrawal. Even though 
a significant number of our patients were being 
tapered from medications with anticholinergic 
potency, we do not think this affected our results 
because the sensitivity of the DST in our sample 
correlates well, and if anything, is slightly lower 
than that previously reported by our unit (Carroll 
et al. 1981) and the medications were tapered 
slowly. 
Abnormal clinical circadian patterns are very 
interesting features of patients with endogenous 
depression. Our patients reported diurnal variation 
in mood, early morning awakening and both fea- 
tures simultaneously in 39%, 47% and 31% of the 
cases respectively. Reported frequencies of diurnal 
variation in mood can vary from no occurrence at 
all to being present in almost every patient (for 
review see Mellerup and Rafaelsen 1979). On the 
6 
other hand, early morning awakening is con- 
sistently reported in approximately half of the 
patients with endogenous depression (Rosenthal 
and Gudeman 1967; Woodruff et al. 1967). As 
previously stated, we found no significant associa- 
tion between these clinical patterns and the post- 
dexamethasone plasma cortisol responses. This 
dissociation may be of relevance to neuroendo- 
crinological research in affective disorders. From 
the clinical and therapeutic point of view, it would 
be of great interest to follow these patients 
throughout the course of their illness and observe 
whether they constitute a different subgroup of 
patients, or whether patients showing circadian 
clinical changes are the ones responsive to ther- 
apeutic manipulations-like sleep deprivation-of 
their chronobiological rhythms. 
The diurnal variation of cortisol secretion has 
been one of the most frequently studied neuroen- 
docrine variables in affective disorder patients. 
Several abnormalities like circadian hypersecre- 
tion, an increased number of secretory episodes, 
the fluctuating of the circadian secretory curve, the 
earlier onset (as related to sleeping time) of corti- 
sol secretory episodes and the abnormal response 
to the DST test have been well established (Sachar 
1976; Carroll et al. 1981; Jarrett et al. 1983). These 
findings suggest significant disturbances of normal 
phasic relationships between the circadian cortisol 
secretory pattern, the sleep-wake cycle and diag- 
nosis of affective disorder. Abnormal hypo- 
thalamic-pituitary-adrenal (H-P-A) axis func- 
tion in affective disorders may be secondary to 
dysfunction of one or more of the several (basal, 
stress-evoked, circadian and feedback release) 
(Krieger 1979) mechanisms involved in ACTH 
release regulation. It may well be that the DST, a 
measure of feedback release, involves different 
neuroanatomical pathways and different neuro- 
transmitter systems than the circadian regulation 
of cortisol secretion; this in turn may explain why 
abnormal DSTs and circadian alterations in mood 
and sleep do not correlate. Therefore, we suggest 
that the study of the H-P-A axis function in 
affective disorders should involve research proce- 
dures and clinical ratings that take into account 
the different possible abnormal mechanisms in- 
volved in cortisol secretion regulation and clinical 
symptom patterns (like diurnal variation in mood 
and early morning awakening). 
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